Evidence map›Paper›PMID 20501851›Full record

ArticleCancer research2010

Plasma fibronectin promotes lung metastasis by contributions to fibrin clots and tumor cell invasion.

Gunjan Malik, Lynn M Knowles, Rajiv Dhir, Shuping Xu, Shuting Yang, Erkki Ruoslahti, Jan Pilch

Open access · bronzeAbstract read
In one paragraph

Article in Cancer research, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 81 papers.

0numbers the graph read from it
0cells of the map it votes in
81citing papers in PubMed
4.9field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

81 citing papers in PubMed, 144 citations in OpenAlex.

  1. Article
  2. Article
  3. Testing cellular provenance in the cancer extracellular matrix.Frontiers in cell and developmental biology · 2026
    Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Fibronectin-targeted FUD and PEGylated FUD peptides for fibrotic diseases.Journal of controlled release : official journal of the Controlled Release Society · 2023
    Article
  15. Article
  16. Article
  17. Review
  18. Review
  19. Article
  20. Article

21 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 1 country.

Gunjan MalikDepartments of Urology and Pathology, University of Pittsburgh School of Medicine, Shadyside Medical Center, Prostate Cancer Program, University of Pittsburgh Cancer Institute, Pittsburgh, PA 15232, USA.
Lynn M Knowles
Rajiv Dhir
Shuping Xu
Shuting Yang
Erkki Ruoslahti
Jan Pilch
Sanford Burnham Prebys Medical Discovery Institute · USUniversity of California, Santa Barbara · USCancer Research Center · USUPMC Hillman Cancer Center · US

Funding

Tumor Microenvironment and Cancer ImmunologyP30CA030199 · NCI · SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE · PI Michael Jackson · 1985 to 2026
$107.2M
Tumor Therapy/Annihilation Using a Smart NanoPlatform (SNaP)U54CA119335 · NCI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI ESENER, SADIK · 2005 to 2010
$21.2M
Clot formation in the tumor stroma as a target for prostate cancer treatmentR01CA134330 · NCI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI PILCH, JAN · 2008 to 2011
$1.2M
NCI NIH HHS CA119335NCI NIH HHS CA134330NCI NIH HHS CA30199NCI NIH HHS P30 CA030199NCI NIH HHS R01 CA134330NCI NIH HHS U54 CA119335
6 · The paper itself

Abstract

The attachment of circulating tumor cells to the blood vessels of distant organs is an important step in metastasis. We show here that experimental lung metastasis by two cell lines, B16F1 melanoma and 3LL lung carcinoma, is greatly reduced in transgenic mice that lack plasma fibronectin. This multifunctional adhesive glycoprotein becomes cross-linked to fibrin during clotting. Here, we report that eliminating plasma fibronectin from the blood circulation reverses the prometastatic effects of blood clotting and tumor cell integrin alphavbeta3. In vitro studies showed that fibrin-fibronectin complexes, but not purified fibrin, supported tumor cell attachment and invasion. These functions correlate with the ability of fibrin-fibronectin complexes to induce the activation of integrin alphavbeta3. Our findings reveal an important contribution of plasma fibronectin in lung metastasis. Furthermore, they suggest that the previously noted effects of blood clotting on lung metastasis might be mediated in part by a fibronectin-alphavbeta3 integrin axis, in which plasma fibronectin has to be incorporated into the blood clot.

Indexed as

AnimalsBlood CoagulationCarcinoma, Lewis LungCell AdhesionFibrinFibronectinsIntegrin alphaVbeta3Lung NeoplasmsMelanoma, ExperimentalMiceMice, Inbred C57BLMice, TransgenicNeoplasm InvasivenessFibrinFibronectinsIntegrin alphaVbeta3

Identifiers

PMID20501851
PMCPMC2880218
OpenAlexW2134655779

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.